Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cancer Research

• Publication date

  1992-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1371717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Biology of Prostate-Specific Antigen

  1991cited by this paper
• Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

  1991cited by this paper
• Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

  1991cited by this paper
• Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP.

  1991cited by this paper
• Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?

  1991cited by this paper
• Activation of protein kinase-C inhibits vitamin D receptor gene expression.

  1991influential reference
• Expression of PSA in LNCaP Cells in Culture

  1991cited by this paper
• Concepts of citrate production and secretion by prostate 1. Metabolic relationships

  1991cited by this paper
• In situ hybridization of prostate-specific antigen mRNA in human prostate.

  1990cited by this paper
• Optimization of northern analysis by vacuum-blotting, RNA-transfer visualization, and ultraviolet fixation.

  1990cited by this paper
• What is new in endocrine therapy of prostatic cancer

  1990cited by this paper
• Overexpression of a partial human androgen receptor in E. coli: characterization of steroid binding, DNA binding, and immunological properties.

  1990cited by this paper
• Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

  1990cited by this paper
• Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

  1990cited by this paper
• What is new in endocrine therapy of prostatic cancer?

  1990cited by this paper
• Regulation of progesterone receptor-mediated transcription by phosphorylation.

  1990cited by this paper
• The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia.

  1989cited by this paper
• Demonstration of the role of prostate-specific antigen in semen liquefaction by two-dimensional electrophoresis.

  1989cited by this paper
• Clinical use of prostate specific antigen in patients with prostate cancer.

  1989cited by this paper
• Testosterone Stimulates Net Citrate Production from Aspartate by Prostate Epithelial Cells

  1988cited by this paper
• Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus.

  1988cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C

  1988cited by this paper
• Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

  1987cited by this paper
• Human prostate-specific antigen: structural and functional similarity with serine proteases.

  1986cited by this paper
• Age-related changes in tissue levels of prostatic acid phosphatase and prostate specific antigen.

  1986cited by this paper
• Characteristics of the β‐adrenergic stimulation of adenylate cyclase activity in rat ventral prostate and its modulation by androgens

  1986cited by this paper
• Studies and perspectives of protein kinase C.

  1986cited by this paper
• Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.

  1986cited by this paper
• Characterization and androgenic regulation of soluble protein kinases and protein phosphorylation in rat ventral prostate gland.

  1986cited by this paper
• Phorbol Diester Modulates α‐Adrenergic Receptor‐Coupled Calcium Efflux and α‐Adrenergic Receptor Number in Cultured Vascular Smooth Muscle Cells

  1986cited by this paper
• A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

  1985cited by this paper
• Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation.

  1985cited by this paper
• Phorbol esters modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells.

  1984cited by this paper
• Epidermal growth factor and potent phorbol tumor promoters induce epidermal growth factor receptor phosphorylation in a similar but distinctively different manner in human epidermoid carcinoma A431 cells.

  1984cited by this paper
• Phorbol ester induces desensitization of adenylate cyclase and phosphorylation of the beta-adrenergic receptor in turkey erythrocytes.

  1984cited by this paper
• Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.

  1983cited by this paper
• Phorbol diester receptor copurifies with protein kinase C.

  1983cited by this paper
• Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

  1983cited by this paper
• Immunoperoxidase localization of prostate‐specific antigen

  1982cited by this paper
• Prostate antigen: A new potential marker for prostatic cancer

  1981cited by this paper
• Prostatic‐specific antigen: An immunohistologic marker for prostatic neoplasms

  1981cited by this paper
• Purification of a human prostate specific antigen.

  1979cited by this paper
• Isolation and characterization of a semen-specific protein from human seminal plasma: a potential new marker for semen identification.

  1978cited by this paper
• Androgenic effects on protein kinases and cyclic AMP-binding protein in the ventral prostate.

  1976influential reference
• Androgenic effects on protein kinases and cyclic AMP-binding protein in the ventral prostate.

  1976cited by this paper
• Isolation and characterization of two specific antigens of human seminal plasma.

  1973cited by this paper
• [Some physico-chemical characteristics of " -seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII].

  1971cited by this paper

• Kinase modulation of androgen receptor signaling: implications for prostate cancer.

  2015cites this paper
• Human Prostatic Acid Phosphatase: Structure, Function and Regulation

  2013cites this paper
• Human Prostatic Acid Phosphatase in Prostate Carcinogenesis

  2013cites this paper
• Functional interplay between melatonin receptor‐mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer

  2011cites this paper
• Modulation of Androgen Receptor Transcriptional Activity

  2009cites this paper
• The Role of Cyclic AMP in Regulating the Androgen Receptor

  2009cites this paper
• Signaling mechanisms of melatonin in antiproliferation of hormone‐refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention

  2007cites this paper
• Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors.

  2007cites this paper
• Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer.

  2007cites this paper
• A novel class of pyranocoumarin anti–androgen receptor signaling compounds

  2007cites this paper
• The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.

  2007cites this paper
• Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.

  2006cites this paper
• Advances in Brief CWR 22 : Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma 1

  2006cites this paper
• Primary Human Prostatic Carcinoma CWR 22 : Androgen-dependent Xenograft Model Derived from a Updated Version

  2006cites this paper
• Prostate-specific antigen and androgen deprivation therapy

  2004cites this paper
• JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA)

  2004cites this paper
• Changes in Prostate-Specific Antigen (PSA) Level Correlate with Growth Inhibition of Prostate Cancer Cells Treated in Vitro with a Novel Anticancer Drug, Irofulven

  2004cites this paper
• Activation of the androgen receptor by polypeptide growth factors and cellular regulators

  2004cites this paper
• The Scaffolding Protein RACK1 Interacts with Androgen Receptor and Promotes Cross-talk through a Protein Kinase C Signaling Pathway*

  2003cites this paper
• Protein kinase C mu is down-regulated in androgen-independent prostate cancer.

  2003cites this paper
• Protein kinase C μ is down-regulated in androgen-independent prostate cancer

  2003cites this paper
• OF THE HUMAN PROSTATIC ACID PHOSPHATASE GENE Tissue-specific and androgen-dependent regulation of the promoter constructs in cell lines and transgenic mice

  2002cites this paper
• TRANSCRIPTIONAL REGULATION OF THE HUMAN PROSTATIC ACID PHOSPHATASE GENE

  2002cites this paper
• Androgen Receptor Phosphorylation

  2002cites this paper
• The biosynthesis of prostate-specific antigen in non prostatic cell lines.

  2001cites this paper
• Fatty acid regulation of protein kinase C isoforms in prostate cancer cells.

  2001cites this paper
• Ligand Dependent and Independent Activation of the Androgen Receptor

  2001cites this paper
• EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON SERUM PSA IN PATIENTS WITH KLINEFELTER SYNDROME

  2001cites this paper
• Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven.

  2001cites this paper
• PROTEIN KINASE C PATHWAY IS INVOLVED IN REGULATING THE SECRETION OF PROSTATIC ACID PHOSPHATASE IN HUMAN PROSTATE CANCER CELLS

  2001cites this paper
• Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.

  2001cites this paper
• Novel strategies and therapeutics for the treatment of prostate carcinoma

  2000cites this paper
• DIFFERENTIAL RESPONSIVENESS OF PROSTATIC ACID PHOSPHATASE AND PROSTATE‐SPECIFIC ANTIGEN mRNA TO ANDROGEN IN PROSTATE CANCER CELLS

  2000influential citation
• Down-regulation of AP1 activities after polarization of vas deferens epithelial cells correlates with androgen-induced gene expression.

  2000cites this paper
• Molecular action of androgen in the normal and neoplastic prostate.

  1999cites this paper
• Androgen-independent Induction of Prostate-specific Antigen Gene Expression via Cross-talk between the Androgen Receptor and Protein Kinase A Signal Transduction Pathways*

  1999cites this paper
• Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer.

  1999cites this paper
• Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma.

  1999cites this paper
• Chapter 4 Tumor markers for prostate cancer

  1999cites this paper
• Androgen regulation of the human ornithine decarboxylase promoter in prostate cancer cells.

  1998cites this paper
• Effects of Ca++ mobilization on expression of androgen‐regulated genes: Interference with androgen receptor‐mediated transactivation by AP‐1 proteins

  1997cites this paper
• Diagnostic and prognostic markers for human prostate cancer

  1997cites this paper
• Synergistic activation of androgen receptor by androgen and luteinizing hormone‐releasing hormone in prostatic carcinoma cells

  1997cites this paper
• The Molecular Biology of the Kallikreins and their Roles in Inflammation

  1997cites this paper
• Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.

  1996cites this paper
• Persistent Membrane Translocation of Protein Kinase C x during I 2O-Tetradecanoylphorbol-1 3-acetate-induced Apoptosis of LNCaP Human Prostate Cancer Cells 1

  1996cites this paper
• Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.

  1996cites this paper
• Expression and androgenic regulation of human prostate-specific kallikreins.

  1995cites this paper
• Prostate specific antigen role and function

  1995cites this paper
• Transcription factors 3: nuclear receptors.

  1995cites this paper
• Secretion of prostate-specific antigen-suppressing activity by two human prostate carcinoma cell lines.

  1995cites this paper
• Effect of exogenous testosterone replacement on prostate‐specific antigen and prostate‐specific membrane antigen levels in hypogonadal men

  1995cites this paper
• Prostatic specific antigen.

  1994cites this paper
• CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.

  1994cites this paper
• Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line.

  1994cites this paper
• Functional Morphology of Prostate Gland

  1994cites this paper
• c-fos promoter insensitivity to phorbol ester and possible role of protein kinase C in androgen-independent cancer cells.

  1994cites this paper
• Inhibition of tumorigenic potential and prostate‐specific antigen expression in LNCaP human prostate cancer cell line by 13‐cis‐retinoic acid

  1994cites this paper
• Regulation of prostate‐specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrotestosterone, and extracellular matrix

  1994cites this paper
• Expression and Androgenic Regulation of Human Prostate-Specific Kallikreins

  1994cites this paper
• Chapter 6 – Biochemistry of Prostatic Carcinoma

  1994cites this paper
• Current Status of Prostate-Specific Antigen in the Radiotherapeutic Management of Prostatic Cancer.

  1993cites this paper
• Hormonal regulation of prostate‐specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

  1992cites this paper